Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.77	6.21	20.75	44.58	69.72	66.84
Short-Term Investments	23.83	34.57	54.31	45.6	37.08	66.98
Cash & Short-Term Investments	31.6	40.78	75.06	90.18	106.8	133.82
Cash Growth	-53.41%	-45.66%	-16.77%	-15.56%	-20.19%	34.00%
Other Receivables	-	0.88	0.99	1	1.13	-
Receivables	-	0.88	0.99	1	1.13	-
Prepaid Expenses	2.23	0.99	1.17	1.2	1.48	1.24
Other Current Assets	-	1.38	0.21	1.36	2.27	2.8
Total Current Assets	33.83	44.04	77.44	93.75	111.67	137.86
Property, Plant & Equipment	0.94	0.81	0.62	0.68	1.43	1.1
Long-Term Investments	-	0.08	0.08	3.58	19.93	50.46
Goodwill	-	-	17.63	-	-	-
Other Intangible Assets	62.37	60.05	63.67	5.9	-	-
Other Long-Term Assets	9.95	9.51	8.47	-	0.19	0.04
Total Assets	107.09	114.48	167.9	103.91	133.23	189.47
Accounts Payable	3.01	2.9	2.03	0.57	4.91	3.56
Accrued Expenses	5.35	3.97	3.12	1.86	8.39	13.16
Current Portion of Leases	-	0.1	0.06	0.45	0.74	0.24
Other Current Liabilities	-	0.31	4.36	0.19	0.18	0.04
Total Current Liabilities	8.36	7.28	9.57	3.07	14.22	17
Long-Term Debt	15.27	14.32	13.43	-	-	-
Long-Term Leases	0.38	0.39	0.32	-	0.42	0.21
Long-Term Deferred Tax Liabilities	5.17	4.96	5.3	0.25	-	-
Other Long-Term Liabilities	59.33	57.38	54.19	-	-	-
Total Liabilities	88.51	84.33	82.82	3.32	14.64	17.2
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	408.08	406.61	401.64	389.11	355.23	318.57
Retained Earnings	-391.5	-376.47	-319.64	-288.26	-236.6	-146.65
Comprehensive Income & Other	1.96	-0.04	3.05	-0.29	-0.08	0.31
Total Common Equity	18.58	30.15	85.08	100.59	118.59	172.26
Shareholders' Equity	18.58	30.15	85.08	100.59	118.59	172.26
Total Liabilities & Equity	107.09	114.48	167.9	103.91	133.23	189.47
Total Debt	15.65	14.81	13.81	0.45	1.16	0.45
Net Cash (Debt)	15.95	25.97	61.25	89.73	105.64	133.37
Net Cash Growth	-70.32%	-57.59%	-31.74%	-15.06%	-20.79%	33.56%
Net Cash Per Share	0.37	0.60	1.64	2.68	3.55	4.57
Filing Date Shares Outstanding	44.09	44	43.22	36.28	30.15	29.55
Total Common Shares Outstanding	44.09	44	42.97	36.14	30.07	29.54
Working Capital	25.47	36.76	67.87	90.68	97.45	120.87
Book Value Per Share	0.42	0.69	1.98	2.78	3.94	5.83
Tangible Book Value	-43.78	-29.9	3.79	94.69	118.59	172.26
Tangible Book Value Per Share	-0.99	-0.68	0.09	2.62	3.94	5.83
Machinery	-	0.89	0.68	0.43	0.61	0.46
Leasehold Improvements	-	0.03	0.04	0.02	0.06	0.02

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q